Human lungs are colonized by a wide variety of commensal bacterial species, although much is still unknown about the role of the microbiome in the lung in health and disease. [1] [2] [3] [4] [5] [6] [7] In particular, it is unknown how microbiome interactions with the local immune system modulate the balance between the protective immune response and inflammation. 8, 9 The gram-negative bacterium nontypeable Haemophilus influenzae (NTHi) is a highly diverse commensal microbe that can become an opportunistic intracellular pathogen. [10] [11] [12] This obligate human pathogen is a leading cause of respiratory tract infections in the very young and elderly and is associated with a range of clinically important infections, including acute otitis media, pneumonia, and bacteremia. 13, 14 NTHi is also commonly associated with lung diseases, such as chronic obstructive pulmonary disease (COPD), which is an increasingly prevalent condition and is predicted to be the third leading cause of death by 2020. [15] [16] [17] Microbial dysbiosis in patients with COPD is dominated by a loss of microbial diversity and overgrowth of key species, with NTHi-induced exacerbations of COPD being the main drivers of disease progression and mortality. 7, 11, 18, 19 In the lung, NTHi appears capable of intracellular survival within macrophages, 20 and this niche might explain the persistence of NTHi in the airway. Cell-mediated immune control of the airway microbiome is not well described, and in particular, responses of T cells to NTHi are not well understood. Interestingly, an increase in CD8
1 T-cell numbers is found in the airway in patients with COPD, but this does not appear to confer increased immunity to bacterial pathogens. 21, 22 Recently, innate-like mucosal-associated invariant T (MAIT) cells have been identified, and these recognize antigens derived from bacterial riboflavin (vitamin B2) synthesis, which are presented by the nonpolymorphic MHC-related protein 1 (MR1). 23 On activation, MAIT cells rapidly express effector cytokines, such as TNF-a, IFN-g, and IL-17, 24, 25 and are also able to inhibit intracellular bacterial growth within infected macrophages. 26 Although conventional T cells largely depend on antigen presentation for activation, MAIT cells can produce IFN-g in response to T-cell receptor-independent IL-12 and IL-18 stimulation. [26] [27] [28] [29] Cytotoxic T cells are vital in the control and clearance of intracellular bacterial pathogens by degranulation of granzymes and perforin. [30] [31] [32] [33] However, little is known about the cytotoxic responses of MAIT cells. Recent work has shown that MAIT cells upregulate cytotoxic mediators, such as granzyme B, but this has not been shown in the lung or in response to respiratory pathogens. [34] [35] [36] The mechanisms controlling MAIT cell cytotoxicity are not fully understood nor is it known how these mechanisms and responses differ from those of conventional T cells.
Because MAIT cells are antibacterial cells residing in the lung, 37, 38 it seems likely that they play a role in host defense to lung pathogens and in the potential surveillance and control of the lung microbiome. Given that there is no current vaccine for NTHi, understanding the mechanisms behind NTHi-induced responses of both conventional and innate-like T cells is important to guide future vaccine development. 39 Here we found that both conventional lung T cells and, more potently, MAIT cells exhibit cytotoxic responses to NTHi infection. We further demonstrate the mechanisms controlling these responses and suggest that innate cytokine signaling controls MAIT granzyme B expression through apparent regulation of the IL-12 receptor (IL-12R).
METHODS

Patient recruitment
Lung tissue distal from tumor sites was obtained from patients undergoing lobectomy. For isolation of T cells and monocytes, blood was obtained from healthy human volunteers. All studies were approved by the Southampton and South West Hampshire Research Ethics Committees (13/SC/0416, 09/H0504/ 109). All participants provided written informed consent.
Preparation of lung tissue and explant infection
NTHi was prepared, as previously described. 40, 41 Lung tissue explants were prepared, as previously described. 42 Tissue explants were infected with 5 3 10 6 colony-forming units of NTHi for 24 hours, after which T cells were dispersed from tissue by means of 0.5 mg/mL collagenase digestion.
Blood T-cell and monocyte isolation and differentiation (MACS; Miltenyi Biotec, Bisley, United Kingdom) and monocyte-derived macrophages (MDMs) differentiated over 12 days by using 2 ng/mL GM-CSF, as previously described. 40 
Macrophage infection
MDM infection was performed, as previously described. 40 Briefly, MDMs were cultured for 2 hours at 378C with NTHi. After 2 hours, MDMs were washed and then incubated either alone or cocultured with autologous T cells for a further 22 hours, unless otherwise indicated. Cell viability was confirmed by means of trypan blue staining.
MAIT cell killing assay
MAIT cells were sorted by means of fluorescence-activated cell sorting (FACS; purity >93%) from autologous T cells and cocultured with MDMs for 48 hours at a 2:1 ratio. Killing of MDMs by MAIT cells was confirmed by means of viability staining.
Flow cytometric analysis
Flow cytometry was performed, as previously described. 40 Cells were first stained for surface markers or appropriate isotype controls. Cells were then resuspended in Cytofix/Cytoperm (BD Biosciences, Oxford, United Kingdom) before staining for intracellular markers. Flow cytometric analysis was performed on a FACSAria with FACSDiva software (version 5.0.3; BD Biosciences). The gating strategy is outlined in Fig 1. 
RNA isolation and RT-PCR
RNA was extracted from MDMs and reverse transcribed to cDNA, as previously described. 40 IL12p35, IL12p40, and IL7 gene expression was analyzed by using TaqMan universal PCR master mix, No AmpErase UNG in a 7900HT Fast Real-Time PCR System instrument (all from Life Technologies, Loughborough, United Kingdom). Gene expression was normalized to b 2 -microglobulin gene expression and quantified by using the DD cycle threshold method.
ELISA
IL-12p70 ELISA MAX (BioLegend, San Diego, Calif) and granzyme B DuoSet ELISA (R&D Systems, Minneapolis, Minn) were all carried out according to the manufacturers' protocol.
Statistics
Statistical analyses were performed with either a Wilcoxon matched-pair signed-rank test or Friedman test with Dunn multiple comparison testing (GraphPad Prism, version 6.0; GraphPad Software, La Jolla, Calif). Data are expressed as medians. Results were considered significant at a P value of less than .05.
For additional information on the methods used in this study, please see the Methods section in this article's Online Repository at www.jacionline.org.
RESULTS
Conventional lung T cells and MAIT cells upregulate cytotoxic markers in response to NTHi
To first determine the cytotoxic responses of conventional lung T cells and MAIT cells to NTHi, human lung tissue explants were infected with NTHi, and cytotoxic responses were measured by using flow cytometry. Gating strategies are outlined in Fig 1. Significant (P < .01) upregulation of granzyme B was detected in lung CD8
1 T cells in response to NTHi infection (Fig 2, A) .
CD4
1 T cells, which are classically associated with cytokine production, also upregulated both granzyme B expression and CD107a levels (both P < .01; Fig 2, B) after infection. Similarly, a significant (P < .01) upregulation of both cytotoxic markers was measured in MAIT cells in response to NTHi (Fig 2, C) (Fig 3, A) . There was no significant increase in either marker when MDMs were infected with paraformaldehyde-killed NTHi (PFA-NTHi), indicating that the cytotoxic response of T cells in this model requires live NTHi infection.
Similar to lung T cells, upregulation of granzyme B and CD107a levels was not restricted to blood CD8 1 T cells. CD4
1
T cells produced a minor but statistically significant increase in both granzyme B (uninfected: 4% vs NTHi: 8%, P 5 .0005) and CD107a (uninfected: 1.7% vs NTHi: 2.5%, P 5 .0015) after coculture with NTHi-infected MDMs (Fig 3, B) . Significant upregulation of both granzyme B (uninfected: 27% vs NTHi: 65%, P 5 .0005) and CD107a (uninfected: 8% vs NTHi: 20%, P 5 .001) was also detected in MAIT cells in response to NTHi infection (Fig 3, C) . PFA-NTHi did not cause upregulation of the cytotoxic markers in either CD4 1 T-cell or MAIT cell subsets. Analysis of coculture supernatants showed that NTHi infection caused a 5-fold increase in granzyme B release (P 5 .01, see Fig E1) .
Both CD4 1 and CD8 1 T cells had a minor but significant (both P < .05) upregulation in perforin levels in response to NTHi infection (see Fig E2 in this article's Online Repository at www.jacionline.org). However, MAIT cells expressed high perforin levels at baseline, which were not upregulated further. For this reason, we decided to concentrate our further studies on CD107a and granzyme B.
Conventional T-cell cytotoxic responses to bacterial infection are completely inhibited by blocking antigen presentation
Cocultures were repeated with the addition of MHC-blocking antibodies to determine whether the NTHi-induced cytotoxic responses of CD8 1 and CD4 1 T cells were antigen dependent. Anti-HLA-ABC and anti-HLA-DR antibodies, respectively, J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 6 significantly reduced CD8 1 and CD4 1 T-cell granzyme B and CD107a levels to baseline (all P < .01, IgG 2a isotype vs blocking antibody; Fig 4, A) . The decrease to baseline values suggests that other factors, such as cytokine activation, are less involved in the conventional T-cell cytotoxic response. For this reason, conventional T cells were not investigated further in this study.
MAIT cell cytotoxic responses are dependent on MR1 in a time-dependent manner
For MAIT cell cytotoxic responses, MR1 blocking was performed in both a 5-hour and a 22-hour coculture model, which is in line with our previous study. 40 At 5 hours, MR1 blocking significantly (P 5 .03) reduced CD107a upregulation back to baseline (IgG 2a isotype: 4.1% vs anti-MR1: 2.6%), but MR1 blocking in the 22-hour coculture did not affect CD107a expression (Fig 4, B) . Conversely, granzyme B upregulation was not blocked at 5 hours, but there was a significant (P 5 .01) inhibition after the 22-hour coculture (IgG 2a isotype: 74% to anti-MR1: 67%; Fig 4, B) . The modest effect of MR1 blocking could not reduce granzyme B expression back to uninfected baseline. Blocking of HLA-DR had no effect on MAIT cell granzyme B, but blocking of HLA-ABC caused only a minor inhibition (see Fig E3, A, in this article's Online Repository at www.jacionline.org). We reasoned that the requirement for MR1 in activating MAIT cells might be time dependent and that MR1-independent factors, such as cytokines, were also responsible for controlling MAIT cell cytotoxic responses. MDMs and T cells were in direct contact (Fig 3, C) . Minor upregulation of MAIT CD107a levels was also observed (Fig 5) . To determine whether contact dependency was required for other MAIT responses, IFN-g levels were also measured and found to be upregulated in the Transwell model, although again to a lesser extent compared with direct contact (see Fig E3, B) . In combination with the MR1 blocking data, we demonstrate that MAIT cells can become activated in the absence of physical contact and antigen presentation, indicating that soluble factors, such as cytokines, can play an important role in MAIT activation during infections. For all graphs, median values are shown; data are from different donors (n 5 8-11) and are paired. Statistical significance was determined by using the Wilcoxon signed-rank test. *P < .05, **P < .01, and ***P < .001.
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MDMs produce IL-12 in response to NTHi infection
Previous reports have shown that IL-12 is capable of driving MAIT cell activation in the setting of Escherichia coli infection, 26, 28 and therefore we investigated whether MR1-independent MAIT activation in our model was driven by IL-12.
NTHi infection led to a significant (P 5 .01) 1200-fold induction of IL12p40 mRNA but did not affect IL12p35 gene expression by MDMs (Fig 6, A) . IL-12p70 protein levels were significantly (P 5 .01) increased from 0 to 290 pg/mL at 22 hours after NTHi infection, but little IL-12p70 protein was detected when MDM supernatants were harvested 5 hours after NTHi infection (Fig 6, B) . No IL-12p70 protein was detected in supernatants from MDMs infected with PFA-NTHi, indicating that nonviable bacteria are not sufficient to induce IL-12 protein production.
To confirm that IL-12 was relevant to the lung, supernatants from NTHi-infected lung explants were analyzed for IL-12 protein.
In agreement with our MDM data, infected explants released a small but significant (P < .01) amount of IL-12p70 (see Fig E4, A, in this article's Online Repository at www.jacionline. org).
Blocking of IL-12 inhibits granzyme B but does not affect CD107a upregulation of NTHi-activated MAIT cells
Once we established that NTHi-infected MDMs release IL-12, MDM-T-cell cocultures were repeated in the presence of an anti-IL-12p40 antibody. A previous report by Kurioka et al 34 showed that IL-12 played a role in modulating MAIT cell granzyme B levels. In agreement with this report, blocking of IL-12p40 in our model significantly (P 5.01) impaired granzyme B upregulation (Fig 6, D) but had no effect on CD107a upregulation (Fig 6, C) . Inhibition of granzyme B was further reduced to baseline levels when both MR1 and IL-12-blocking antibodies were present (P 5 .03; Fig 6, E) . Together with the MR1 blocking, our data show that the mechanisms of MAIT cell activation in response to NTHi are time dependent, with both MR1-dependent and IL-12-dependent responses.
IL-12 stimulation can induce MAIT cell granzyme B expression in the absence of antigen presentation
We next sought to determine whether IL-12 alone was sufficient to induce MAIT cell granzyme B activation to the same extent as NTHi-infected MDMs. We found that stimulation of T cells alone with IL-12 causes a minor increase in MAIT cell granzyme B levels (P 5 Fig 6, F) .
IL-7 is expressed by macrophages and contributes to granzyme B upregulation
To understand why the IL-12-induced granzyme B upregulation was greater in the presence of MDMs, we reasoned that MDMs can produce other cytokines, which synergized with IL-12 to induce granzyme B expression. A previous report by Leeansyah et al 43 showed that stimulation of MAIT cells with IL-7 caused upregulation of granzyme B. Therefore we hypothesized that IL-7 was also involved in upregulation of granzyme B in our model. Quantitative PCR indicated that MDMs express IL7 mRNA in response to NTHi infection (Fig 7, A) . NTHi-infected MDMs were then stained to detect the presence of intracellular IL-7 protein by using flow cytometry. MDMs appeared to express IL-7 at baseline, and this was upregulated after NTHi infection (P 5 .03; Fig 7, A) .
T cells alone were then stimulated with IL-12, IL-7, or both, and granzyme B expression was measured by using flow cytometry. Individually, IL-7 and IL-12 caused a minor upregulation in MAIT cell granzyme B levels. However, combined IL-12 and IL-7 stimulation synergistically caused greater granzyme B expression (P < .001; Fig 7, B) , which was similar to the levels observed with NTHi infection. Consistent with this, IL-7 blocking in the NTHi-infected coculture model led to a significant decrease in MAIT granzyme B expression (P < .05; Fig 7, C) . Taken together, our data show that granzyme B expression in MAIT cells can be activated by combined IL-12 and IL-7 signaling.
IL-12R is upregulated on MAIT cells after NTHi infection in a mechanism dependent on IL-12 and IL-7
We hypothesized that granzyme B upregulation could be controlled by expression of either the IL-12 or IL-7 receptor, and therefore expression of both receptors was first measured on MAIT cells in the NTHi-infected coculture. NTHi infection upregulated both IL-12Rb1 and IL-12Rb2 on MAIT cells A, Gene expression of IL12a (p35) and IL12b (p40) expressed as DD cycle threshold normalized to b 2 -microglobulin. B, IL-12p70 expression measured by means of ELISA. C-E, CD107a (Fig 6, C) and granzyme B (Fig 6, D and E -7) and are paired. Statistical significance was determined by using the Wilcoxon signed-rank test. *P < .05.
(P <.05; Fig 7, D) . In contrast, IL-7 receptor (IL-7R) a expression on MAIT cells was significantly decreased after infection (P < .05; Fig 7, D) . IL-12Rb2 was also significantly (P < .05) upregulated on lung MAIT cells from NTHi-infected explants (see Fig E4, B) .
Finally, to deduce how IL-12 and IL-7 synergistically combine to control MAIT granzyme B expression, IL-12R and IL-7R levels were measured after stimulation of T cells alone with IL-12, IL-7, or both. IL-12Rb1 expression was unaffected by stimulation with either cytokine, whereas IL-7 stimulation led to a significant decrease in IL-7Ra expression (P < .001; Fig 7, E) . However, MAIT cell IL-12Rb2 expression was upregulated in the presence of both cytokines (P < .01; Fig 7, E) . Taken together, these data show that IL-7 in combination with IL-12 synergistically upregulates MAIT cell IL-12Rb2 expression, which might allow greater IL-12 signaling, resulting in upregulation of MAIT cell granzyme B expression.
Killing of NTHi-infected MDMs by MAIT cells
The coculture model was adapted so that MDMs were cocultured with pure FACS-sorted MAIT cells and macrophage death was assessed by means of viability staining to confirm that MAIT cells were capable of actually killing NTHi-infected MDM. At 24 hours, no increase in MAIT cell-induced MDM death from MDM-MAIT cell coculture was detected (data not shown). However, at 48 hours, there was a significant (P 5 .03) increase in MAIT cell-induced death of NTHi-infected MDMs compared with uninfected MDMs, indicating that MAIT cells are capable of killing NTHi-infected macrophages (Fig 8, A and  B) . Consistent with this, an increase in lactate dehydrogenase levels was detected in NTHi-infected MDM-MAIT cell cocultures (data not shown). MAIT cell granzyme B levels were also significantly (P < .05) upregulated in response to NTHi infection in this killing assay at 48 hours (Fig 8, C) . Overall, we show that MAIT cells are cytotoxic cells that respond to NTHi infection and kill infected macrophages.
DISCUSSION
MAIT cells are rapidly gaining recognition as important effector cells with potential roles in a variety of diseases. Here, for the first time, we show that human lung MAIT cells exhibit cytotoxic responses to the respiratory pathogen NTHi. In combination with our previous study, 40 these observations provide further evidence that NTHi represents a target of lung MAIT cell immunity.
Little is known about the mechanisms behind MAIT cell cytotoxic responses or how they differ from those of conventional T cells. Here conventional CD4
1 and CD8 1 T-cell granzyme B responses were dependent exclusively on antigen presentation. In contrast, MAIT cell expression of granzyme B was regulated through a combination of both MR1 antigen presentation and through IL-12 and IL-7 stimulation. The ability of MAIT cells to upregulate granzyme B in response to cytokines might represent a mechanism that allows MAIT cells to become primed and respond rapidly to infection.
Previous studies have also reported that IL-12 and IL-7 are involved in MR1-independent MAIT cell IFN-g and cytotoxic responses. 26, 28, 43 However, to our knowledge, this is the first study that links IL-12 and IL-7 stimulation in a novel mechanism whereby both cytokines synergize to positively regulate IL-12R, allowing increased IL-12 signaling and leading to greater granzyme B upregulation.
Because IL-7, IL-12, IL-15, and IL-18 have all been reported to activate MAIT cells, further work is needed to explore the full interactions and combined effects of these cytokines on MAIT cell activation. 44, 45 The ability of MAIT cells to respond to cytokine stimulation alone expands their definition as antibacterial cells and indicates a role for bystander activation in patients with infections with non-riboflavin-synthesizing bacteria and viruses. [45] [46] [47] Diseases characterized by an increased inflammatory environment could also result in bystander activation of MAIT cells, furthering inflammation. Indeed, increased levels of IL-12 have been found in patients with COPD and inversely correlate with lung function. 48 Whether increased IL-12 mediates lung function decrease by activating MAIT cell cytotoxicity is a question that remains to be addressed.
In addition to upregulation of cytotoxic markers, we show that MAIT cells are able to kill NTHi-infected MDMs, but because of technical limitations, we were unable to demonstrate that IL-12/IL-7 blocking actually impaired the killing ability of MAIT cells. However, increases in granzyme B levels correlated with increases in killing, suggesting a role for IL-12/IL-7 in this killing mechanism. Further work will be required to fully address this.
Although upregulation of granzyme B is controlled by IL-12 and IL-7, degranulation appeared to be largely dependent on cell contact and antigen presentation. This would indicate that although MAIT cells can substantially accumulate cytotoxic mediators intracellularly in response to cytokine stimulation, cytotoxic release is mainly controlled by cell contact. However, because the requirement for MR1 in degranulation appeared to be time dependent and because minor CD107a upregulation was also seen in the Transwell setup, other noncontact factors can contribute to degranulation. Overall, it seems likely that MR1 is required to initiate MAIT cell degranulation but is not required in the beginning to induce granzyme B expression. Initial degranulation can release other granzymes, such as granzyme A and granzyme K, whereas granzyme B release occurs later. 34 The type of pathogen, intracellular location of the pathogen, inflammatory environment, and type of infected cell might all be factors in determining the extent to which MAIT cell activation is MR1 dependent or independent. Indeed, the responses in our Transwell model were surprising at first because a previous report using Transwells showed that MAIT cells did not activate in the absence of cell-to-cell contact, possibly because of a lack of expression of IL-12 or IL-7 in that system. 49 Anatomic location might also be important because a recent study found that granzyme B production by MAIT cells from pleural effusions of patients with tuberculosis was not inhibited by IL-12 blocking. 50 The time course of activation could also be a key factor in determining which pathway predominates for MAIT cell activation. Ussher et al 28 found that short incubations of infected antigen-presenting cells caused IFN-g upregulation by MAIT cells in an MR1-mediated manner but longer incubations meant that MAIT cell activation was dependent on both MR1 and IL-12.
Although conventional cytotoxic T cells are typically thought of as just CD8
1
, CD4
1 T cells have also been found to express CD107a after viral challenge 51 and are known to express granzyme B 52 but have not been investigated in the context of J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 6
NTHi infection. Wilkinson et al 51 also found an inverse correlation between CD4 1 cells and symptoms after viral challenge, suggesting an important role of CD4 1 cytotoxic activity in response to influenza infection. The data presented here might also suggest a role for cytotoxic CD4 1 cells in responding to NTHi infection.
The mechanisms involved in NTHi colonizing the lower airways and becoming pathogenic are not well understood but could potentially be due to impaired T-cell responses as a result of cigarette smoke-induced damage. [53] [54] [55] Previously, we have shown that cytotoxic T cells are dysregulated in the lungs of patients with COPD by means of aberrant regulation of the programmed cell death protein 1 signaling pathway, and this might be a mechanism through which T cells contribute to excessive inflammation in response to respiratory pathogens. 42 Future work is needed to understand the mechanisms controlling T-cell activation and how these become impaired in diseases associated with chronic NTHi colonization. -6 ) and are paired. Statistical significance was determined by using the Wilcoxon signed-rank test or Friedman test with the Dunn multiple comparison. *P < .05 **P < .01, and ***P < .001. = J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 6 In summary, we show here that both conventional T cells and, more potently, MAIT cells demonstrate cytotoxic responses to NTHi infection. We have also highlighted important differences in the mechanisms of innate and adaptive T-cell cytotoxic responses. Further work is needed to understand the mechanisms behind innate and adaptive T-cell responses to bacterial pathogens in patients with airways diseases. More importantly, with their ability to respond to cytokine stimulation, MAIT cells could be an important source of bystander inflammation and cytotoxic agent-mediated damage in patients with a variety of lung diseases and infections. Therefore this observation provides both a new understanding of protective immune mechanisms and potential new therapeutic opportunities to modulate this response and improve clinical outcome.
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METHODS Preparation of NTHi
A strain of NTHi cultured from the sputum of a patient with COPD from Southampton was used, as previously described. E1 Briefly, NTHi was cultured on chocolate agar plates, and colonies were used to inoculate brain-heart infusion medium supplemented with 10 mg/L nicotinamide adenine dinucleotide, 30 mg/L hemin, and 44 mL/L glycerol. The bacterial suspension was grown to mid-log phase, and heat-inactivated FCS was added at a final concentration of 20%. One-milliliter aliquots were stored at 2808C, as previously described.
E2
Patient recruitment
For ex vivo human explant experiments, lung tissue distal from tumor sites was obtained from patients undergoing lung resection surgery performed at Southampton General Hospital. Blood was obtained from healthy volunteers for isolation of T cells and monocytes for in vitro experiments. All studies were approved by the Southampton and South West Hampshire Research Ethics Committees (13/SC/0416, 09/H0504/109). All participants provided written informed consent.
Preparation of lung tissue and explant infection
Lung tissue explants were prepared, as previously described. E3 Briefly, lung tissue obtained from patients undergoing lung resectioning was taken from sites distal to any tumors present. Lung tissue was cut into 3-to 5-mm 3 cubes and washed extensively before being placed in RPMI (Sigma-Aldrich, Poole, United Kingdom) supplemented with 2 mg/mL L-glutamine, 1% gentamicin, and 0.5 mg/mL amphotericin B (all from Invitrogen, Paisley, United Kingdom) and incubated overnight at 378C in a 5% CO 2 atmosphere. Tissue explants were then infected with 5 3 10 6 colony-forming units of NTHi for 24 hours, after which T cells were dispersed from tissue by means of 0.5 mg/mL collagenase digestion. T cells were then stained for flow cytometry.
Blood T-cell and monocyte isolation and differentiation
CD3
1 T cells and CD14 1 monocytes were isolated from human PBMCs obtained from the blood of healthy volunteers by using magnetic cell sorting (MACS; Miltenyi Biotec) and MDMs over 12 days by using 2 ng/mL GM-CSF, as previously described. E1 CD3 1 cells were frozen at 2808C in 10% dimethyl sulfoxide in FCS until needed. CD3 1 T cells were chosen so as to not exclude double-negative (CD4
2
CD8
2 ) MAIT cells.
Macrophage infection
MDM infection was performed, as previously described. E1 Briefly, MDMs were cultured for 2 hours at 378C with either live or paraformaldehyde-fixed NTHi at a multiplicity of infection of 10 in antibiotic-free 0.1% FCS-RPMI. After 2 hours, MDMs were washed and then incubated either alone or with autologous T cells in 0.1% FCS-RPMI with antibiotics for a further 22 hours, unless otherwise indicated. Where specified, cocultures were carried out with the addition of either anti-MR1 (26.5), anti-HLA-DR (L243), anti-HLA-ABC (W6/32), anti-IL-12 (C8.6), or anti-IL-7 (BVD10-40F6) or appropriate isotype controls at 5 or 10 mg/mL, as indicated (all from BioLegend). For cytokine stimulation, cells were incubated with 10 ng/mL recombinant IL-12 or IL-7, as indicated (both from BioLegend). Monensin was added to the final 5 hours of culture to measure intracellular IL-7 levels. Cell viability was confirmed by means of trypan blue staining.
MAIT killing assay
MDMs were infected as described above and were cocultured with autologous FACS-sorted MAIT cells to create a pure MDM-MAIT cell coculture (>93% purity). MDMs and MAIT cells were cocultured for 48 hours, after which cells were harvested. MDMs were stained for HLA-DRallophycocyanin (APC)-CY7 (BD Biosciences) and for viability with Zombie Violet Fixable Viability Kit (BioLegend). The percentage death of MDMs alone (not cocultured with MAIT cells) was deducted from percentage death of MDMs from MDM-MAIT cell cocultures to determine specific MAIT cell-induced killing of NTHi-infected MDMs.
Flow cytometric analysis
All cells were resuspended in 100 mL of FACS buffer (2 mmol/L EDTA and 0.5% wt/vol BSA in PBS) with 2 mg/mL purified IgG from human serum (Sigma-Aldrich) per tube. Cells were stained for surface markers or appropriate isotype controls for 30 minutes on ice. Cells were then washed and resuspended in 200 mL of Cytofix/Cytoperm (BD Biosciences) and incubated on ice for 20 minutes. After fixation, cells were washed in 13 Perm/Wash, resuspended in 100 mL of 13 Perm/Wash buffer, and stained for intracellular markers on ice for 30 minutes. Cells were then washed again and resuspended in FACS buffer. T cells were stained for surface markers: CD4-peridinin-chlorophyll-protein-CY5.5, CD8-APC-CY7, CD161-APC, and CD107a-BV510 (all from BD Biosciences); Va7.2-phycoerythrin (PE) and IL-7Ra-BV510 (both from BioLegend); and IL-12Rb1-fluorescein isothiocyanate (FITC) and IL-12Rb2-Alexa Fluor 488 (R&D Systems). T cells were stained intracellularly for IFN-g-FITC, perforin-FITC (BioLegend), and granzyme B-FITC (BD Biosciences). Staining for lung T cells was identical to the above, with the addition of CD3-PE-CY7 (BD Biosciences). For MDM-IL-7 staining, MDMs were first fixed and permeabilized as above and then stained intracellularly for purified human anti-IL-7 (BVD10-40F6) and then anti-rat IgG 1 -PE (MRG1-58; both from BioLegend). Specific mean fluorescence intensity was derived by subtracting isotype fluorescence values from each sample's mean fluorescence intensity.
Flow cytometric analysis was performed on a FACSAria with FACSDiva software (version 5.0.3; BD Biosciences). The gating strategy is outlined in Fig 1. 
RNA isolation and RT-PCR
RNA was extracted from MDMs by using TriFast (PeqLab; VWR, Erlangen, Germany). Reverse transcription was performed according to the manufacturer's protocols by using a High Capacity cDNA Reverse Transcription Kit (Life Technologies) with random hexamers. IL12p35, IL12p40, and IL7 gene expression was analyzed by using TaqMan universal PCR master mix, No AmpErase UNG, in a 7900HT fast real-time PCR system instrument (all from Life Technologies). Gene expression was normalized to b 2 -microglobulin gene expression and quantified by using the DD cycle threshold method.
ELISA IL-12p70 ELISA MAX (BioLegend) and granzyme B DuoSet ELISA (R&D Systems) were all carried out according to the manufacturers' protocols.
Statistics
Statistical analyses were performed with either a Wilcoxon matched-pairs signed-rank test or Friedman test with the Dunn multiple comparison test (version 6.0; GraphPad Prism). Data are expressed as medians. Results were considered significant at a P value of less than .05.
FIG E1.
Granzyme B is produced in response to NTHi infection. Supernatants from lung explants or autologous MDM-T-cell cocultures were measured for granzyme B expression by using ELISA. Median values are shown; data are from different donors (n 5 6-7) and are paired. Statistical significance was determined by using the Wilcoxon signed-rank test. *P < .05 and **P < .01. Statistical significance was determined by using the Wilcoxon signed-rank test. **P < .01.
